EP3568204
PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND AN SHP2 INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.1.2018EP published:
30.8.2023EP application number:
18701574.8
EPO information:
European Patent Register
Max expiry date:
7.1.2038
Title in English:
PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND AN SHP2 INHIBITORLanguage of the patent:
English
Timeline
Today
8.1.2018EP application
30.8.2023EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Name:
THE GENERAL HOSPITAL CORPORATION DBA MASSACHUSETTS GENERAL HOSPITALAddress:
55 Fruit Street, Boston, MA 02114, US
Inventor
Name:
DARDAEI ALGHALANDIS, LeilaAddress:
Cambridge, Massachusetts 02139, US
Name:
ENGELMAN, Jeffrey AdamAddress:
Cambridge, Massachusetts 02139, US
Name:
HAO, HuaixiangAddress:
Cambridge, Massachusetts 02139, US
Name:
LI, FangAddress:
Arlington, Massachusetts 02476, US
Name:
LAMARCHE, Matthew J.Address:
Cambridge, Massachusetts 02139, US
Name:
WANG, Hui-QinAddress:
Cambridge, Massachusetts 02139, US
Priority
Number:
201762444493 PDate:
10.1.2017Country:
US
Classification
Categories:
A61K 31/4353, A61P 35/00, A61K 45/06, A61K 31/4439, A61K 31/506, A61K 31/513, A61K 31/519, A61K 31/53, A61K 31/5375